logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
M

Michio Nakamura

sapporo city general hospital
H指数:32
被引数:3,784

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A multicenter, prospective, observational study of nivolumab readministration for advanced gastric cancer (NIVO RETURNS)

一项关于纳武利尤单抗再给药用于晚期胃癌的多中心、前瞻性、观察性研究（NIVO RETURNS）

FUTURE ONCOLOGY
IF2.6
2025-05-080
PRE
Kodama, Hiroyuki; Narita, Yukiya; Nakamura, Michio; Takahashi, Masanobu; Mizukami, Takuro; Ando, Takayuki; Mitani, Seiichiro; Komori, Azusa; Hosokawa, Ayumu; Sugiyama, Keiji; Taguri, Masataka; Orihara, Shunichiro; Kagamu, Hiroshi; Yamaguchi, Toshifumi; Nishikawa, Hiroki; Muro, Kei
Systemic treatment for patients with advanced Merkel cell carcinoma in Japan: A multicenter retrospective study

日本晚期 Merkel 细胞癌患者的系统性治疗：一项多中心回顾性研究

ANNALS OF ONCOLOGY
IF65.4
2024-12-010
PRE
Nakano, E.; Nakamura, M.; Kawashima, S.; Maruyama, A.; Ohe, S.; Kato, J.; Fujimura, T.; Omata, W.; Funakoshi, T.; Fujisawa, Y.; Maekawa, T.; Yamakawa, K.; Hatta, N.; Nakama, K.; Ito, T.; Matsushita, S.; Miyagawa, T.; Oashi, K.; Yamamoto, Y.; Namikawa, K.
A multicenter, prospective, phase II trial of second-line aflibercept plus FOLFIRI in patients with metastatic colorectal cancer refractory to an anti-EGFR antibody: HGCSG1801
INTERNATIONAL JOURNAL OF CANCER
IF4.7
2024-08-142
OA
Nakatsumi, Hiroshi; Komatsu, Yoshito; Harada, Kazuaki; Kawamoto, Yasuyuki; Yuki, Satoshi; Sawada, Kentaro; Ishiguro, Atsushi; Sogabe, Susumu; Ando, Takayuki; Sasaki, Yusuke; Yoshikawa, Ayumu; Nakamura, Michio; Dazai, Masayoshi; Tateyama, Miki; Muto, Osamu; Kotaka, Masahito; Sagawa, Tamotsu; Muranaka, Tetsuhito; Hatanaka, Kazuteru; Takagi, Ryo; Sakata, Yu
Correlation of UGT1A1 Gene Polymorphisms or Prior Irinotecan Treatment and Treatment Outcomes of Nanoliposomal-Irinotecan plus 5-Fluorouracil/Leucovorin for Pancreatic Ductal Adenocarcinoma: A Multicenter, Retrospective Cohort Study (HGCSG2101)
JOURNAL OF CLINICAL MEDICINE
IF2.9
2023-02-173
OAAI
Harada, Kazuaki; Yamamura, Takahiro; Muto, Osamu; Nakamura, Michio; Sogabe, Susumu; Sawada, Kentaro; Nakano, Shintaro; Yagisawa, Masataka; Muranaka, Tetsuhito; Dazai, Masayoshi; Tateyama, Miki; Kobayashi, Yoshimitsu; Kato, Sosuke; Hatanaka, Kazuteru; Kawamoto, Yasuyuki; Yuki, Satoshi; Sakata, Yuh; Sakamoto, Naoya; Komatsu, Yoshito
Study protocol for HGCSG1801: A multicenter, prospective, phase II trial of second-line FOLFIRI plus aflibercept in patients with metastatic colorectal cancer refractory to anti-EGFR antibodies
FRONTIERS IN ONCOLOGY
IF3.3
2022-11-091
OAAI
Nakatsumi, Hiroshi; Komatsu, Yoshito; Muranaka, Tetsuhito; Yuki, Satoshi; Kawamoto, Yasuyuki; Harada, Kazuaki; Dazai, Masayoshi; Tateyama, Miki; Sasaki, Yusuke; Miyagishima, Takuto; Tsuji, Yasushi; Katagiri, Masaki; Nakamura, Michio; Sogabe, Susumu; Hatanaka, Kazuteru; Meguro, Takashi; Kobayashi, Tomoe; Ishiguro, Atsushi; Muto, Osamu; Shindo, Yoshiaki; Kotaka, Masahito; Ando, Takayuki; Takagi, Ryo; Sakamoto, Naoya; Sakata, Yu
REVIVE study: An observational study in chemotherapy (CTx) after nivolumab (NIVO) for advanced gastric cancer (AGC)
ANNALS OF ONCOLOGY
IF65.4
2022-07-010
OAAI
Sakamoto, Yasuhiro; Narita, Yukiya; Misumi, Toshihiro; Matsuoka, Hiroshi; Tanioka, Hiroaki; Kawakami, Takeshi; Matsushima, Tomohiro; Miwa, Hiroto; Shoji, Hirokazu; Ishiguro, Atsushi; Fushida, Sachio; Miura, Kou; Yamada, Takanobu; Shinozaki, Katsunori; Mizukami, Takuro; Nishina, Tomohiro; Moriwaki, Toshikazu; Mitani, Seiichiro; Nakamura, Michio; Muro, Kei
HGCSG 1603: A phase 2 trial of ramucirumab plus irinotecan as second-line treatment for advanced gastric cancer
ANNALS OF ONCOLOGY
IF65.4
2021-07-010
PREAI
Sawada, Kentaro; Kawamoto, Yasuyuki; Yuki, Satoshi; Nakamura, Michio; Muto, Osamu; Sogabe, Susumu; Shindo, Ysohiaki; Ishiguro, Atsushi; Sato, Atsushi; Tsuji, Yasushi; Dazai, Masayoshi; Okuda, Hiroyuki; Sasaki, Takahide; Harada, Kazuaki; Nakano, Shintaro; Nakatsumi, Hiroshi; Sekiguchi, Mari; Sakata, Yuh; Sakamoto, Naoya; Komatsu, Yoshito
HGCSG1901: A retrospective cohort study evaluating the safety and efficacy of S-1 and irinotecan plus bevacizumab in patients with metastatic colorectal cancer: Analysis of first-line treatment
ANNALS OF ONCOLOGY
IF65.4
2021-07-010
OAAI
Ito, K.; Yuki, S.; Nakano, S.; Yagisawa, M.; Sawada, K.; Ishiguro, A.; Muto, O.; Hatanaka, K.; Okuda, H.; Sato, A.; Sasaki, Y.; Nakamura, M.; Sasaki, T.; Kobayashi, T.; Dazai, M.; Nakatsumi, H.; Ueda, A.; Tateyama, M.; Sogabe, S.; Matsumoto, R.; Sakata, Y.; Komatsu, Y.
HGCSG1901: A retrospective cohort study evaluating the safety and efficacy of S-1 and irinotecan plus bevacizumab in patients with metastatic colorectal cancer: Analysis of second-line treatment after anti-EGFR antibody
ANNALS OF ONCOLOGY
IF65.4
2021-07-010
PREAI
Yoshikawa, A.; Ito, K.; Yuki, S.; Kawamoto, Y.; Saito, R.; Yamamura, T.; Yagisawa, M.; Ishiguro, A.; Muto, O.; Hatanaka, K.; Okuda, H.; Sato, A.; Sasaki, Y.; Nakamura, M.; Sasaki, T.; Kobayashi, T.; Dazai, M.; Nakatsumi, H.; Ueda, A.; Sakata, Y.; Komatsu, Y.

研究方向

暂未获取到该数据
S
Satoshi Yuki
H 指数:24论文数:460被引数:2,248
Y
Yoshito Komatsu
H 指数:54论文数:829被引数:1.5万
Y
Yasuyuki Kawamoto
H 指数:18论文数:218被引数:1,880
S
Susumu Sogabe
H 指数:10论文数:92被引数:369
A
Atsushi Ishiguro
H 指数:17论文数:196被引数:1,005
O
Osamu Muto
H 指数:8论文数:95被引数:245
M
Masayoshi Dazai
H 指数:5论文数:109被引数:364
K
Kazuteru Hatanaka
H 指数:13论文数:200被引数:611
Y
Yasushi Tsuji
H 指数:33论文数:361被引数:4,361
H
Hiroshi Nakatsumi
H 指数:7论文数:135被引数:242